Nacho Aguiló

3.6k total citations
73 papers, 2.5k citations indexed

About

Nacho Aguiló is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Nacho Aguiló has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 38 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Nacho Aguiló's work include Tuberculosis Research and Epidemiology (38 papers), Immune responses and vaccinations (31 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Nacho Aguiló is often cited by papers focused on Tuberculosis Research and Epidemiology (38 papers), Immune responses and vaccinations (31 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Nacho Aguiló collaborates with scholars based in Spain, France and United Kingdom. Nacho Aguiló's co-authors include Carlos Martı́n, Dessislava Marinova, Jesús Gonzalo‐Asensio, Santiago Uranga, Julián Pardo, Alberto Anel, Marta Monzón, Juan José Badiola, Martín Villalba and Eugenia Puentes and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Nacho Aguiló

72 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nacho Aguiló Spain 31 1.4k 1.4k 813 694 236 73 2.5k
Angelo Izzo United States 28 1.6k 1.1× 2.3k 1.7× 1.4k 1.7× 895 1.3× 191 0.8× 70 3.3k
Steven C. Derrick United States 24 1.5k 1.0× 2.4k 1.8× 1.5k 1.9× 808 1.2× 179 0.8× 42 3.2k
Nargis Khan India 23 1.7k 1.2× 937 0.7× 403 0.5× 710 1.0× 150 0.6× 44 2.4k
Stephen T. Reece Germany 21 614 0.4× 1.1k 0.8× 716 0.9× 520 0.7× 102 0.4× 38 1.7k
Gregory W. Martens United States 20 849 0.6× 552 0.4× 519 0.6× 523 0.8× 94 0.4× 24 1.8k
Buka Samten United States 30 904 0.6× 1.3k 0.9× 1.1k 1.4× 536 0.8× 146 0.6× 64 2.3k
Ugo D’Oro Italy 31 1.6k 1.1× 359 0.3× 722 0.9× 1.1k 1.5× 240 1.0× 56 2.9k
Bingdong Zhu China 21 530 0.4× 775 0.6× 434 0.5× 554 0.8× 93 0.4× 65 1.3k
Richard F. Silver United States 25 729 0.5× 1.2k 0.8× 992 1.2× 372 0.5× 131 0.6× 40 2.1k
Timo Ulrichs Germany 20 979 0.7× 1.5k 1.1× 1.2k 1.5× 456 0.7× 128 0.5× 45 2.4k

Countries citing papers authored by Nacho Aguiló

Since Specialization
Citations

This map shows the geographic impact of Nacho Aguiló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nacho Aguiló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nacho Aguiló more than expected).

Fields of papers citing papers by Nacho Aguiló

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nacho Aguiló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nacho Aguiló. The network helps show where Nacho Aguiló may publish in the future.

Co-authorship network of co-authors of Nacho Aguiló

This figure shows the co-authorship network connecting the top 25 collaborators of Nacho Aguiló. A scholar is included among the top collaborators of Nacho Aguiló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nacho Aguiló. Nacho Aguiló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casal, Margarida, et al.. (2025). NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in mice. Cancer Gene Therapy. 32(10). 1090–1097.
2.
Esteso, Gloria, et al.. (2024). Selective expansion of anti-tumor innate lymphocytes in long-term cultures after a single BCG pulse. Methods in cell biology. 190. 203–221. 1 indexed citations
3.
Álvarez, Marco Polo Peralta, Andrew White, Laura Sibley, et al.. (2024). MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates. npj Vaccines. 9(1). 230–230. 1 indexed citations
4.
Robles‐Vera, Iñaki, Santiago Uranga, Ana Belén Gómez, et al.. (2023). Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung. Nature Communications. 14(1). 6090–6090. 18 indexed citations
5.
Uranga, Santiago, Ana Belén Gómez, Denise Nardelli‐Haefliger, et al.. (2022). Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors. Journal for ImmunoTherapy of Cancer. 10(7). e004325–e004325. 13 indexed citations
6.
Pardo‐Seco, Jacobo, Nacho Aguiló, Ana Dacosta-Urbieta, et al.. (2021). BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies. EBioMedicine. 65. 103254–103254. 11 indexed citations
7.
Dijkman, Karin, Nacho Aguiló, Charelle Boot, et al.. (2021). Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection. Cell Reports Medicine. 2(1). 100187–100187. 33 indexed citations
8.
Uranga, Santiago, Ana Belén Gómez, Dessislava Marinova, et al.. (2021). Therapeutic efficacy of pulmonary live tuberculosis vaccines against established asthma by subverting local immune environment. EBioMedicine. 64. 103186–103186. 7 indexed citations
9.
Farrell, Damien, Santiago Uranga, Ana Belén Gómez, et al.. (2020). Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference. PLoS Pathogens. 16(12). e1009061–e1009061. 4 indexed citations
10.
Solans, Luis, Anne‐Sophie Debrie, Lisa Borkner, et al.. (2018). IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine. Mucosal Immunology. 11(6). 1753–1762. 67 indexed citations
11.
Uranga, Santiago, Dessislava Marinova, Carlos Martı́n, Julián Pardo, & Nacho Aguiló. (2016). Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo. PLoS ONE. 11(4). e0153028–e0153028. 9 indexed citations
12.
Uranga, Santiago, Dessislava Marinova, Carlos Martı́n, & Nacho Aguiló. (2016). Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice. Journal of Visualized Experiments. 13 indexed citations
13.
Aguiló, Nacho, Santiago Uranga, Dessislava Marinova, et al.. (2015). MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice. Tuberculosis. 96. 71–74. 51 indexed citations
14.
Solans, Luis, Santiago Uranga, Nacho Aguiló, et al.. (2014). Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice. Vaccine. 32(40). 5192–5197. 22 indexed citations
15.
Arbués, Ainhoa, Nacho Aguiló, Jesús Gonzalo‐Asensio, et al.. (2013). Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. Vaccine. 31(42). 4867–4873. 190 indexed citations
16.
Arbués, Ainhoa, Nacho Aguiló, Marta Monzón, et al.. (2012). Attenuated Mycobacterium tuberculosis SO2 Vaccine Candidate Is Unable to Induce Cell Death. PLoS ONE. 7(9). e45213–e45213. 31 indexed citations
17.
Aguiló, Nacho, Johan Garaude, Julián Pardo, Martín Villalba, & Alberto Anel. (2009). Protein Kinase C-θ Is Required for NK Cell Activation and In Vivo Control of Tumor Progression. The Journal of Immunology. 182(4). 1972–1981. 31 indexed citations
18.
Aguiló, Nacho, Johan Garaude, Geoffroy de Bettignies, et al.. (2009). ERK5 Knockdown Generates Mouse Leukemia Cells with Low MHC Class I Levels That Activate NK Cells and Block Tumorigenesis. The Journal of Immunology. 182(6). 3398–3405. 26 indexed citations
19.
Pardo, Julián, Nacho Aguiló, Alberto Anel, et al.. (2009). The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes and Infection. 11(4). 452–459. 91 indexed citations
20.
Garaude, Johan, Sandra Kaminski, Nacho Aguiló, et al.. (2008). Impaired anti-leukemic immune response in PKCθ-deficient mice. Molecular Immunology. 45(12). 3463–3469. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Izzo Breakdown of academic impact, for papers by Steven C. Derrick Breakdown of academic impact, for papers by Nargis Khan Breakdown of academic impact, for papers by Stephen T. Reece Breakdown of academic impact, for papers by Gregory W. Martens Breakdown of academic impact, for papers by Buka Samten Breakdown of academic impact, for papers by Ugo D’Oro Breakdown of academic impact, for papers by Bingdong Zhu Breakdown of academic impact, for papers by Richard F. Silver Breakdown of academic impact, for papers by Timo Ulrichs
Rankless by CCL
2026